Status:
COMPLETED
VIABAHN BX Used in Fenestrated EVAR Study
Lead Sponsor:
University Health Network, Toronto
Conditions:
Aortic Aneurysm, Abdominal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fenestrated endovascular abdominal aortic aneurysm repair (FEVAR) is a procedure to treat abdominal aortic aneurysms which are not amenable to conventional repair or stenting. A stent is placed in the...
Detailed Description
FEVAR branches can occlude jeopardizing perfusion of the organs they supply. A recent study has shown the rate of patency as 95.7% at 1 year and 88.6% at 4 years. Pooled analysis has shown a 4.5% rate...
Eligibility Criteria
Inclusion
- Fenestrated EVAR candidates as determined by the vascular interdisciplinary conference at UHN
Exclusion
- Unable to provide informed consent (legally authorized representative is acceptable)
- Age \< 18
- Patients with a known hypersensitivity to heparin, including those patients who have had a previous incidence of HIT (heparin induced thrombocytopenia) type II.
- Currently participating in another investigative clinical study
Key Trial Info
Start Date :
February 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03310710
Start Date
February 13 2017
End Date
November 1 2019
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network, Toronto General Hospital
Toronto, Ontario, Canada, M5G 2N2